The pharmaceutical industry is a major contributor to the global economy, with global sales estimated at $1.2 trillion in 2018 and projected to reach over $1.5 trillion by 2023. However, this industry is also vulnerable to counterfeiting, with global trade in counterfeit medicines estimated at $16.2 billion in 2013, representing more than 3.3% of overall commerce in pharmaceutical products. The medical device industry is also affected by counterfeiting and fraudulent activity, particularly in developing nations where the World Health Organization (WHO) estimates that 10% of medical products are either below standard or fake. Counterfeit pharmaceuticals can pose serious risks to people’s health, with some being of extremely poor quality and potentially harmful or even deadly. To protect against these risks, it is important to ensure that pharmaceutical and medical equipment brands are protected. 

Proact Business Intelligence offers services for protecting these trademarks, including a team of anti-counterfeiting specialists and advanced technologies to quickly identify and take action against infringements. Contact us for a free brand review to see how we can assist you in protecting your brand